Colonic Stem Cells Expression of Lgr5 and CD133 Proteins as Predictive Markers in Colorectal Cancer among Egyptian Patients
DOI:
https://doi.org/10.3889/oamjms.2018.208Keywords:
Colonic cancer, Lgr5, CD133, IHC, PolypAbstract
AIM: Colorectal cancer is the fourth common tumour in Egypt after lymphoid, breast and urinary tumours. The study aims to assess the expression of Lgr5 and CD133 in pre-malignant (adenomatous polyps and IBD), malignant colorectal lesions and normal colonic mucosa by immunohistochemical staining.
MATERIAL AND METHODS: This prospective study was done on 100 patients presenting with colonic symptoms, patients were divided into four groups; group I including 20 patients in the control group, group II including 20 ulcerative colitis (U.C) patients, group III including 20 patients with adenomatous polyps and group IV including 40 patients with colorectal cancer (CRC).
RESULTS: Lgr5 and CD133 expression was significantly higher in carcinoma than in adenomas, IBD and normal mucosa (P < 0.001). Lrg5 and CD133 was positively correlated with histological grade (P = 0.001), depth of invasion (P = 0.001), lymph node metastasis (P < 0.001), distant metastasis (P < 0.004) and TNM stage (P < 0.001).
CONCLUSION: Role of Lgr5 and CD133 as stem cell marker was expressed and presented with different expression in the normal colonic mucosa, adenoma and CRC and showed increased expression in an advanced stage of CRC. This may suggest its possible involvement in colorectal tumorigenesis and invasion.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer. J Clin. 2013; 63 (1): 11–30. https://doi.org/10.3322/caac.21166 PMid:23335087
Huang EH, Wicha MS. Colon cancer stem cells: Implications for prevention and therapy. Trends Mol Med. 2008; 14 (11): 503–509. https://doi.org/10.1016/j.molmed.2008.09.005 PMid:18929507 PMCid:PMC2789402
Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells Perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res. 2006; 66 (19): 9339–44. https://doi.org/10.1158/0008-5472.CAN-06-3126 PMid:16990346
Hill RP and Perris R. "Destemming" cancer stem cells. J Natl Cancer Inst. 2007; 99 (19):1435–1440. https://doi.org/10.1093/jnci/djm136 PMid:17895479
Becker L, Huang Q and Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2010; 23 (2):168-174. https://doi.org/10.1111/j.1442-2050.2009.00979.x PMid:19549212
Femia AP, Dolara P, Salvadori M, Caderni G. Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis, correlation with nuclear β-catenin. BMC Cancer. 2013; 13:48. https://doi.org/10.1186/1471-2407-13-48 PMid:23374535 PMCid:PMC3566940
Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63 (18): 5821–5828. PMid:14522905
O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445 (7123): 106-110. https://doi.org/10.1038/nature05372 PMid:17122772
Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445 (7123): 111–115. https://doi.org/10.1038/nature05384 PMid:17122771
Itoi H, Fujimori Y, Tsutsui H, Matsui K, Hada T, Kakishita E, Okamura H, Hara H, Nakanishi K. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice. J Interferon Cytokine Res. 2004; 24(5):291-6. https://doi.org/10.1089/107999004323065075 PMid:15153312
Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, et al. TGFâ€beta signalling in colon carcinogenesis. Cancer Lett. 2012; 314 (1): 1–7. https://doi.org/10.1016/j.canlet.2011.09.041 PMid:22018778
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 2006; 23(8):1097–1104. https://doi.org/10.1111/j.1365-2036.2006.02854.x PMid:16611269
Fabrizi E, di Martino S, Pelacchi F and Ricci-Vitiani L. Therapeutic implications of colon cancer stem cells. World J Gastroenterol. 2010; 16(31): 3871–3877. https://doi.org/10.3748/wjg.v16.i31.3871 PMid:20712047 PMCid:PMC2923760
Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer. 2011; 128 (11): 2511–2526. https://doi.org/10.1002/ijc.26027 PMid:21365648
Brooks SA, Lomaxâ€Browne HJ, Carter TM, et al. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010; 112 (1): 3–25. https://doi.org/10.1016/j.acthis.2008.11.022 PMid:19162308
Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008; 118(6): 2111-2120. https://doi.org/10.1172/JCI34401
Barker N, Van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2009; 449 (7165): 1003-1007. https://doi.org/10.1038/nature06196 PMid:17934449
Fan Y, Chong YS, Choolani MA, Cregan MD and Chan JKY. Unravelling the mystery of stem/progenitor cells in human breast milk. PLoS One. 2010; 5(12):e14421. https://doi.org/10.1371/journal.pone.0014421 PMid:21203434 PMCid:PMC3010984
Takeda K, Kinoshita I, Shimizu Y, et al. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res. 2011; 31(1): 263–270. PMid:21273608
Simon E, Diana P, Christine B et al. The Spatial Distribution of LGR5+ Cells Correlates with Gastric Cancer Progression. PLoS One. 2012; 7(4):e35486. https://doi.org/10.1371/journal.pone.0035486 PMid:22530031 PMCid:PMC3329462
Takahashi H, Ishii H, Nishida N, et al. Significance of Lgr5 (+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol. 2011; 18 (4): 1166-1174. https://doi.org/10.1245/s10434-010-1373-9 PMid:21125339
Yang K, Chen X, Zhang B, et al. Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis. Int J Biol Markers. 2011; 26(3): 173–180. https://doi.org/10.5301/JBM.2011.8551 PMid:21786247
Hongo K, Kazama S, Sunami E, et al. Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer. Med Oncol. 2012; 29(4):2849–2857. https://doi.org/10.1007/s12032-012-0161-8 PMid:22246526 PMCid:PMC3466429
Choi D, Lee HW, Hur KY, et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol. 2009; 15(18):2258-2264. https://doi.org/10.3748/wjg.15.2258 PMid:19437567 PMCid:PMC2682242
Horst D, Scheel SK, Liebmann S, et al. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol. 2009; 219 (4):427–434. https://doi.org/10.1002/path.2597 PMid:19621338
Kojima M, Ishii G, Atsumi N, et al. Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study. Cancer Sci. 2008; 99(8):1578–1583. https://doi.org/10.1111/j.1349-7006.2008.00849.x PMid:18754869
Wang T, Yeoh K, Salto-Tellez M. Lgr5 expression is absent in human premalignant lesions of the stomach. Gut. 2012; 61(12):1777-8. https://doi.org/10.1136/gutjnl-2012-302372 PMid:22442165
Coco C, Zannoni GF, Caredda E, et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. Journal of Experimental & Clinical Cancer Research. 2012; 31: 71. https://doi.org/10.1186/1756-9966-31-71 PMid:22964035 PMCid:PMC3541988
Saigusa S, Tanaka K, Toiyama Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant after chemoradiotherapy. Ann Surg Oncol. 2009; 16(12): 3488–3498. https://doi.org/10.1245/s10434-009-0617-z PMid:19657699
Merlos SA, Barriga FM, Jung P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011; 8 (5): 524.
Uchida H, Yamazaki K, Fukuma M, et al. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Science. 2010; 101(7):1731–1737. https://doi.org/10.1111/j.1349-7006.2010.01571.x PMid:20384634
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
